Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10837021 Curing for recursive nucleic acid-guided cell editing

Patent 10837021 was granted and assigned to Inscripta on November, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 17, 2020

Patent Application Number

16892679

Date Filed

June 4, 2020

Patent Citations

US Patent 10266851 Using programmable DNA binding proteins to enhance targeted genome modification

US Patent 10017760 Methods for generating barcoded combinatorial libraries

US Patent 10011849 Nucleic acid-guided nucleases

Patent Citations Received

US Patent 11965186 Nucleic acid-guided nickases

0

US Patent 11512297 Affinity tag for recombination protein recruitment

US Patent 11542633 Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells

US Patent 11884924 Dual strand nucleic acid-guided nickase editing

0

US Patent 11891609 Methods for increasing observed editing in bacteria

0

US Patent 11473214 Automated instrumentation for production of T-cell receptor peptide libraries

US Patent 11001831 Simultaneous multiplex genome editing in yeast

US Patent 11591592 Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells using microcarriers

...

Patent Primary Examiner

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10837021 Curing for recursive nucleic acid-guided cell editing

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool